Determinants of all-cause mortality in different age groups in patients with severe systolic left ventricular dysfunction receiving an implantable cardioverter defibrillator (from the Italian ClinicalService Multicenter Observational Project)

American Journal of Cardiology

Volumn 113, Issue 10, 2014, Pages 1691-1696

  Fumagalli, Stefano ^a   Gasparini, Maurizio ^b   Landolina, Maurizio ^c   Lunati, Maurizio ^d   Boriani, Giuseppe ^e   Proclemer, Alessandro ^f   Santini, Massimo ^g   Mangoni, Lorenza ^h   Padeletti, Margherita ^a   Marchionni, Niccolò ^a   Padeletti, Luigi ^a,i  

^a UNIVERSITY OF FLORENCE   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^g SAN FILIPPO NERI HOSPITAL   (Italy)

^h Medtronic Italia   (Italy)

ⁱ Humanitas Gavazzeni Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT;

ADULT; ALL CAUSE MORTALITY; ARTICLE; CARDIAC IMPLANT; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KIDNEY FAILURE; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROGNOSIS; SENESCENCE; SURVIVAL RATE;

AGE FACTORS; AGED; CAUSE OF DEATH; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; ITALY; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL RATE; SYSTOLE; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84899750289     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.02.025     Document Type: Article

References (29)

1. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, E.J. Benjamin, J.D. Berry, W.B. Borden, D.M. Bravata, S. Dai, E.S. Ford, C.S. Fox, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D.M. Makuc, G.M. Marcus, A. Marelli, D.B. Matchar, C.S. Moy, D. Mozaffarian, M.E. Mussolino, G. Nichol, N.P. Paynter, E.Z. Soliman, P.D. Sorlie, N. Sotoodehnia, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, and M.B. Turner Heart disease and stroke statistics-2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
2. I. Goldenberg, J. Gillespie, A.J. Moss, W.J. Hall, H. Klein, S. McNitt, M.W. Brown, I. Cygankiewicz, and W. Zareba Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II Circulation 122 2010 1265 1271
3. A.D. Krahn, S.J. Connolly, R.S. Roberts, and M. Gent Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death Am Heart J 147 2004 837 840
4. D.P. Zipes, A.J. Camm, M. Borggrefe, A.E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A.J. Moss, R.J. Myerburg, S.G. Priori, M.A. Quinones, D.M. Roden, M.J. Silka, C. Tracy, S.C. Smith Jr., A.K. Jacobs, C.D. Adams, E.M. Antman, J.L. Anderson, S.A. Hunt, J.L. Halperin, R. Nishimura, J.P. Ornato, R.L. Page, B. Riegel, S.G. Priori, J.J. Blanc, A. Budaj, A.J. Camm, V. Dean, J.W. Deckers, C. Despres, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J.L. Tamargo, and J.L. Zamorano ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J Am Coll Cardiol 48 2006 e247 e346
5. A.E. Epstein, G.N. Kay, V.J. Plumb, H.T. McElderry, H. Doppalapudi, T. Yamada, J. Shafiroff, Z.A. Syed, and S. Shkurovich Implantable cardioverter-defibrillator prescription in the elderly Heart Rhythm 6 2009 1136 1143
6. R. Cutro, M.W. Rich, and P.J. Hauptman Device therapy in patients with heart failure and advanced age: too much too late? Int J Cardiol 155 2012 52 55
7. M. Landolina, M. Gasparini, M. Lunati, S. Iacopino, G. Boriani, C. Bonanno, A. Vado, A. Proclemer, A. Capucci, C. Zucchiatti, S. Valsecchi, R.P. Ricci, and M. Santini Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database Circulation 123 2011 2526 2535
8. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, T.G. Ganiats, M. Jessup, M.A. Konstam, D.M. Mancini, K. Michl, J.A. Oates, P.S. Rahko, M.A. Silver, L.W. Stevenson, and C.W. Yancy 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
9. I. Cygankiewicz, J. Gillespie, W. Zareba, M.W. Brown, I. Goldenberg, H. Klein, S. McNitt, S. Polonsky, M. Andrews, E.M. Dwyer, W.J. Hall, and A.J. Moss Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter- defibrillators Heart Rhythm 6 2009 468 473
10. V. Tsai, M.K. Goldstein, H.H. Hsia, Y. Wang, J. Curtis, P.A. Heidenreich on behalf of the National Cardiovascular Data Registry Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individuals J Am Geriatr Soc 59 2011 1589 1595
11. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1 S266
12. S. Fumagalli, S. Valsecchi, G. Boriani, M. Gasparini, M. Landolina, M. Lunati, M. Padeletti, F. Tronconi, N. Marchionni, and L. Padeletti Comparison of the usefulness of cardiac resynchronization therapy in three age-groups (<65, 65-74 and ≥75 years) (from the InSync/InSync ICD Italian Registry) Am J Cardiol 107 2011 1510 1516
13. J.A. Dodson, R. Lampert, Y. Wang, S.C. Hammill, P. Varosy, and J.P. Curtis Temporal trends in quality of care among ICD recipients: insights from the NCDR(R) Circulation 129 2014 580 586
14. D.T. Huang, H.W. Sesselberg, S. McNitt, K. Noyes, M.L. Andrews, W.J. Hall, A. Dick, J.P. Daubert, W. Zareba, and A.J. Moss Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy J Cardiovasc Electrophysiol 18 2007 833 838
15. P. Santangeli, L. Di Biase, R.A. Dello, M. Casella, S. Bartoletti, P. Santarelli, G. Pelargonio, and A. Natale Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators Ann Intern Med 153 2010 592 599
16. S. Brullmann, W. Dichtl, U. Paoli, L. Haegeli, C. Schmied, J. Steffel, C. Brunckhorst, F. Hintringer, B. Seifert, F. Duru, and T. Wolber Comparison of benefit and mortality of implantable cardioverter-defibrillator therapy in patients aged ≥75 years versus those <75 years Am J Cardiol 109 2012 712 717
17. D. Yung, D. Birnie, P. Dorian, J.S. Healey, C.S. Simpson, E. Crystal, A.D. Krahn, Y. Khaykin, D. Cameron, Z. Chen, and D.S. Lee Survival after implantable cardioverter-defibrillator implantation in the elderly Circulation 127 2013 2383 2392
18. I. Klem, J.W. Weinsaft, T.D. Bahnson, D. Hegland, H.W. Kim, B. Hayes, M.A. Parker, R.M. Judd, and R.J. Kim Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation J Am Coll Cardiol 60 2012 408 420
19. C.M. Dougherty, and J. Hunziker Predictors of implantable cardioverter defibrillator shocks during the first year J Cardiovasc Nurs 24 2009 21 28
20. R.E. Eckart, L.J. Gula, M.R. Reynolds, E.A. Shry, and W.H. Maisel Mortality following defibrillator implantation in patients with renal insufficiency J Cardiovasc Electrophysiol 17 2006 940 943
21. G.Z. Duray, J. Schmitt, S. Richter, C.W. Israel, and S.H. Hohnloser Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period Europace 11 2009 1462 1468
22. J. Kreuz, F. Horlbeck, J. Schrickel, M. Linhart, R. Fimmers, F. Mellert, G. Nickenig, and J.O. Schwab Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention Clin Cardiol 35 2012 575 579
23. K.M. Stein, S. Mittal, F.R. Gilliam, D.M. Gilligan, Q. Zhong, S.M. Kraus, and T.E. Meyer Predictors of early mortality in implantable cardioverter-defibrillator recipients Europace 11 2009 734 740
24. A. Barsheshet, A.J. Moss, D.T. Huang, S. McNitt, W. Zareba, and I. Goldenberg Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator J Am Coll Cardiol 59 2012 2075 2079
25. W. Whang, C.M. Albert, S.F. Sears Jr., R. Lampert, J.B. Conti, P.J. Wang, J.P. Singh, J.N. Ruskin, J.E. Muller, and M.A. Mittleman Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study J Am Coll Cardiol 45 2005 1090 1095
26. D. Chiarantini, S. Volpato, F. Sioulis, F. Bartalucci, L. Del Bianco, I. Mangani, G. Pepe, F. Tarantini, A. Berni, N. Marchionni, and M. Di Bari Lower extremity performance measures predict long-term prognosis in older patients hospitalized for heart failure J Card Fail 16 2010 390 395
27. A. Kinch Westerdahl, J. Sjoblom, A.C. Mattiasson, M. Rosenqvist, and V. Frykman Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life Circulation 129 2014 422 429
28. A. Proclemer, D. Muser, A. Campana, M. Zoni-Berisso, M. Zecchin, A. Locatelli, M. Brieda, L. Gramegna, M. Santarone, L. Chiodi, P. Mazzone, L. Rebellato, and D. Facchin Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] study Int J Cardiol 168 2013 1416 1421
29. S.M. Al Khatib, A. Hellkamp, G.H. Bardy, S. Hammill, W.J. Hall, D.B. Mark, K.J. Anstrom, J. Curtis, H. Al Khalidi, L.H. Curtis, P. Heidenreich, E.D. Peterson, G. Sanders, N. Clapp-Channing, K.L. Lee, and A.J. Moss Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials JAMA 309 2013 55 62